Abera Bioscience AB (NGM:ABERA)

Abera Bioscience AB Statistics

Total Valuation

NGM:ABERA has a market cap or net worth of SEK 114.38 million. The enterprise value is 106.43 million.

Market Cap	114.38M
Enterprise Value	106.43M

Important Dates

The last earnings date was Monday, August 18, 2025.

Earnings Date	Aug 18, 2025
Ex-Dividend Date	n/a

Share Statistics

NGM:ABERA has 15.35 million shares outstanding. The number of shares has increased by 212.65% in one year.

Current Share Class	15.35M
Shares Outstanding	15.35M
Shares Change (YoY)	+212.65%
Shares Change (QoQ)	+8.52%
Owned by Insiders (%)	6.47%
Owned by Institutions (%)	n/a
Float	14.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.27
PB Ratio	14.72
P/TBV Ratio	14.72
P/FCF Ratio	21.23
P/OCF Ratio	18.57
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-118.65
EV / Sales	6.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	19.75

Financial Position

The company has a current ratio of 1.79

Current Ratio	1.79
Quick Ratio	1.43
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -10.83% and return on invested capital (ROIC) is -8.74%.

Return on Equity (ROE)	-10.83%
Return on Assets (ROA)	-5.79%
Return on Invested Capital (ROIC)	-8.74%
Return on Capital Employed (ROCE)	-14.91%
Revenue Per Employee	3.14M
Profits Per Employee	-179,400
Employee Count	5
Asset Turnover	1.26
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +95.29% in the last 52 weeks. The beta is 1.03, so NGM:ABERA's price volatility has been similar to the market average.

Beta (5Y)	1.03
52-Week Price Change	+95.29%
50-Day Moving Average	7.64
200-Day Moving Average	6.19
Relative Strength Index (RSI)	47.07
Average Volume (20 Days)	13,220

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NGM:ABERA had revenue of SEK 15.72 million and -897,000 in losses. Loss per share was -0.04.

Revenue	15.72M
Gross Profit	15.72M
Operating Income	-1.16M
Pretax Income	-897,000
Net Income	-897,000
EBITDA	-1.03M
EBIT	-1.16M
Loss Per Share	-0.04

Balance Sheet

The company has 7.95 million in cash and n/a in debt, giving a net cash position of 7.95 million or 0.52 per share.

Cash & Cash Equivalents	7.95M
Total Debt	n/a
Net Cash	7.95M
Net Cash Per Share	0.52
Equity (Book Value)	7.77M
Book Value Per Share	0.51
Working Capital	4.84M

Cash Flow

In the last 12 months, operating cash flow was 6.16 million and capital expenditures -772,000, giving a free cash flow of 5.39 million.

Operating Cash Flow	6.16M
Capital Expenditures	-772,000
Free Cash Flow	5.39M
FCF Per Share	0.35

Margins

Gross margin is 100.00%, with operating and profit margins of -7.36% and -5.70%.

Gross Margin	100.00%
Operating Margin	-7.36%
Pretax Margin	-5.70%
Profit Margin	-5.70%
EBITDA Margin	-6.53%
EBIT Margin	-7.36%
FCF Margin	34.27%

Dividends & Yields

NGM:ABERA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-212.65%
Shareholder Yield	n/a
Earnings Yield	-0.78%
FCF Yield	4.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NGM:ABERA has an Altman Z-Score of 2.6 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.6
Piotroski F-Score	3